Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to | --- | --- | |-------------------------------------------------------------------------------------------------------|----------------------------- ...

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Q1 2019 Earnings Conference Call May 8, 2019 8:30 AM ET Company Participants David Price - CFO Nancy Lurker - President and CEO Conference Call Participants Andrew D'Silva - B. Riley FBR Yi Chen - H.C. Wainwright Operator Good morning. My name is Skyler, and I will be your conference operator today. At this time, I would like to welcome everyone to the EyePoint Pharmaceuticals' first quarter 2019 financial results conference call. There will be a question and ans ...